1. Home
  2. Browse Decisions
  3. NOVARTIS PHARMA AG v. REGENERON PHARMACEUTICALS, INC.
 

NOVARTIS PHARMA AG v. REGENERON PHARMACEUTICALS, INC.

No. 2023-1334.

NOVARTIS PHARMA AG, NOVARTIS TECHNOLOGY LLC, NOVARTIS PHARMACEUTICALS CORPORATION, Appellants, v. REGENERON PHARMACEUTICALS, INC., Appellee

United States Court of Appeals, Federal Circuit.

Decided: September 23, 2024.

Attorney(s) appearing for the Case

WILLIAM M. JAY, Goodwin Procter LLP, Washington, DC, argued for appellants. Also represented by GERARD J. CEDRONE, JOSHUA WEINGER, Boston, MA. ELIZABETH HOLLAND, Allen Overy Shearman Sterling US LLP, New York, NY; WILLIAM G. JAMES, II, Washington, DC.

ANISH R. DESAI, Weil, Gotshal & Manges LLP, New York, NY, argued for appellee. Also represented by ADAM BANKS, ELIZABETH WEISWASSER; PRIYATA PATEL, CHRISTOPHER PEPE, Washington, DC.

Before PROST, REYNA, and CHEN, Circuit Judges.

NOTE: This disposition is nonprecedential.

Novartis Pharma AG, Novartis Technology LLC, and Novartis Pharmaceuticals Corporation (collectively, Novartis) appeal from a Patent Trial and Appeal Board (Board) final written decision finding all claims of U.S. Patent No. 9,220,631 ('631 patent) unpatentable under 35 U.S...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases